Explore more publications!

Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

Press releases published on March 17, 2026

ハイパーサーム・アソシエイツ、Powermax33 XP を発表 より高出力と高い価値を実現した、コンパクトなプロフェッショナルグレードのプラズマシステム
Hypertherm Associates, Powermax33 XP 출시
Students Turn Raw News Data Into Visual Stories at 2026 Newsmatics Hackathon in Brno
Palm Holdings Ltd. (ADGM) Highlights Strong Global Demand for Its Premium Silver Bars
Palm Holdings Ltd. (ADGM) Highlights Strong Global Demand for Its Premium Silver Bars
Palm Holdings Ltd. (ADGM) Highlights Strong Global Demand for Its Premium Silver Bars
Keystone Marble & Granite Enhances Custom Countertop Fabrication Services in PA & NJ
NatureGlyco Blood Support Claims Evaluated: The Proven Glyco Care Formula for Healthy Blood Sugar Support
Mesoblast to Host R&D Day on April 8, 2026
ZenaTech desarrolla un dron interceptor autónomo de bajo costo y de un solo uso para el sistema Counter-UAS de ZenaDrone para uso en defensa de EE. UU., Medio Oriente y Ucrania
DentaBiome Claims Evaluated: 2026 Oral Postbiotic Consumer Warning Report Issued
MEDVi GLP-1 Weight Loss Claims Evaluated: 2026 Report Examining "Most Trusted Online Medical Care" Positioning, Telehealth Structure, and Regulatory Context
As NVIDIA Maps $1 Trillion AI Factory Buildout, 0G Delivers the Decentralized Alternative — Live on Mainnet
News Release Re Shareholder Rights Plan
Gundry MD Ultimate H2: Most Effective Hydrogen Tablets for Hydrating Water
Gemini Updates Timing of Fourth Quarter and Full Year 2025 Results Conference Call
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Warmysender Reached 10000 Users, Now Support Multichannel Outreach and 20M Leads Database
Phoenix Energy Reports Q4 and Full-Year 2025 Financial Results with Record Revenue and EBITDA
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions